Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 04:00PM ET
2.84
Dollar change
-0.98
Percentage change
-25.66
%
Index- P/E- EPS (ttm)-0.29 Insider Own26.90% Shs Outstand9.44M Perf Week56.91%
Market Cap27.07M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.30M Perf Month14.52%
Income-2.40M PEG- EPS next Q- Inst Own4.70% Short Float0.04% Perf Quarter-
Sales- P/S- EPS this Y0.00% Inst Trans- Short Ratio0.01 Perf Half Y-
Book/sh1.07 P/B2.65 EPS next Y- ROA-34.20% Short Interest0.00M Perf Year-
Cash/sh0.00 P/C- EPS next 5Y- ROE-46.90% 52W Range1.42 - 4.98 Perf YTD-3.40%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-42.97% Beta-
Dividend TTM- Quick Ratio0.10 Sales past 5Y- Gross Margin100.00% 52W Low100.00% ATR (14)0.60
Dividend Ex-Date- Current Ratio0.10 EPS Y/Y TTM- Oper. Margin- RSI (14)- Volatility38.90% 22.05%
Employees7 Debt/Eq0.26 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.12 EPS Q/Q- Payout0.00% Rel Volume2.38 Prev Close3.82
Sales Surprise- EPS Surprise- Sales Q/Q-68.90% Earnings- Avg Volume113.43K Price2.84
SMA2037.43% SMA5030.90% SMA20030.90% Trades Volume269,714 Change-25.66%
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.